Hospital
Emhfl, INC.
Emhfl, INC. was paid $21.53M by Medicaid between Jan 2018 and Dec 2024, across 147 billing codes. Its largest line is 74177, Computed tomography, abdomen and pelvis; with contrast material — 13% of everything it billed.
33Billing provider infoEMHFL, INC.
STANFORD, KY 40484
STANFORD, KY 40484
33aNPI1932254265assigned 01/25/2007
33bProvider typeCritical Access Hospital
28Total paid$21.53M
24GClaims407,140
24DCodes billed147
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Critical Access Hospital providers in Kentucky
Rank by total paid#4 of 16
Median peer was paid$11.73M
This provider vs. median1.8×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 45,496 | $2.43M | |
| 2019 | 54,892 | $2.96M | |
| 2020 | 50,650 | $2.54M | |
| 2021 | 73,021 | $3.66M | |
| 2022 | 68,800 | $3.42M | |
| 2023 | 60,956 | $3.35M | |
| 2024incomplete | 53,325 | $3.17M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 13% | 2,155 | 1,944 | $2.75M |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 11% | 20,222 | 18,178 | $2.28M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 10% | 14,201 | 12,397 | $2.17M |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 8.3% | 8,666 | 7,320 | $1.78M |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 7.3% | 1,570 | 1,405 | $1.57M |
| 70450 | Computed tomography, head or brain; without contrast material | 4.1% | 2,181 | 1,938 | $887K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 2.6% | 9,388 | 8,460 | $557K |
| 41899 | Unlisted procedure, dentoalveolar structures | 2.6% | 636 | 576 | $550K |
| 80053 | Comprehensive metabolic panel | 2.5% | 36,571 | 26,912 | $536K |
| 96375 | Therapeutic injection; each additional sequential IV push | 2.5% | 5,603 | 4,905 | $534K |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | 2.0% | 4,204 | 3,596 | $434K |
| 71045 | Radiologic examination, chest; single view | 1.7% | 5,588 | 5,044 | $376K |
135 more codes
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 1.7% | 1,971 | $365K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 1.6% | 5,086 | $351K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 1.5% | 5,713 | $326K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 1.4% | 4,014 | $310K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 1.3% | 5,330 | $279K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 1.2% | 2,316 | $269K |
| 36415 | Collection of venous blood by venipuncture | 1.2% | 41,277 | $250K |
| 71046 | Radiologic examination, chest; 2 views | 1.1% | 3,719 | $247K |
| 87631 | 1.0% | 1,848 | $219K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 1.0% | 24,059 | $218K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 9,041 | $194K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 10,548 | $183K |
| 80061 | Lipid panel | <1% | 9,768 | $182K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 292 | $181K |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | <1% | 3,418 | $175K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 4,527 | $153K |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 8,263 | $151K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 3,040 | $134K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 2,419 | $122K |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 3,004 | $110K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 2,125 | $107K |
| 80306 | <1% | 3,141 | $106K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 5,407 | $97K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 1,161 | $85K |
| G0330 | Facility services for dental rehabilitation procedure(s) performed on a patient who requires monitored anesthesia (e.g., general, intravenous sedation (monitored anesthesia care) and use of an operating room | <1% | 85 | $82K |
| 73630 | <1% | 1,182 | $82K | |
| 84484 | <1% | 4,028 | $79K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 6,284 | $78K |
| 81001 | <1% | 13,118 | $76K | |
| 82607 | <1% | 3,900 | $75K | |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 11,695 | $74K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 6,419 | $74K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 625 | $71K |
| 73610 | <1% | 1,051 | $69K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 5,662 | $69K |
| 73130 | <1% | 924 | $65K | |
| 83690 | <1% | 5,329 | $63K | |
| 87077 | <1% | 6,225 | $62K | |
| 84439 | <1% | 4,129 | $54K | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 1,335 | $50K |
| 84703 | <1% | 4,086 | $48K | |
| 85027 | <1% | 6,223 | $43K | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 1,197 | $42K |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | <1% | 1,556 | $42K |
| 80074 | <1% | 634 | $40K | |
| 73560 | <1% | 597 | $38K | |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | <1% | 1,102 | $36K |
| 87186 | <1% | 3,083 | $35K | |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 153 | $33K |
| 59025 | Fetal non-stress test | <1% | 697 | $31K |
| 83605 | <1% | 1,771 | $29K | |
| 87486 | <1% | 1,238 | $29K | |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | <1% | 85 | $27K |
| 73110 | <1% | 395 | $27K | |
| 83880 | <1% | 718 | $27K | |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 593 | $26K |
| 87070 | <1% | 1,709 | $26K | |
| 84153 | <1% | 1,183 | $25K | |
| 87581 | <1% | 843 | $24K | |
| 84702 | <1% | 1,234 | $24K | |
| 74018 | <1% | 393 | $24K | |
| 73030 | <1% | 320 | $23K | |
| 84145 | <1% | 860 | $22K | |
| 85610 | <1% | 3,102 | $20K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 765 | $19K |
| G0378 | Hospital observation service, per hour | <1% | 159 | $19K |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | <1% | 472 | $19K |
| 12001 | <1% | 124 | $18K | |
| 82728 | <1% | 1,083 | $18K | |
| 86140 | <1% | 1,878 | $18K | |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 898 | $18K |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 47 | $18K |
| 83921 | <1% | 746 | $17K | |
| J0131 | Injection, acetaminophen, not otherwise specified,10 mg | <1% | 1,029 | $17K |
| 82043 | <1% | 2,690 | $15K | |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 402 | $15K |
| 83735 | <1% | 1,301 | $14K | |
| 71275 | Computed tomographic angiography, chest, with contrast material | <1% | 26 | $13K |
| 85379 | <1% | 793 | $12K | |
| 83540 | <1% | 1,252 | $9K | |
| 83550 | <1% | 1,022 | $9K | |
| 85730 | <1% | 1,133 | $9K | |
| 72100 | <1% | 133 | $9K | |
| 80050 | General health panel | <1% | 353 | $9K |
| 87430 | <1% | 568 | $9K | |
| 82550 | <1% | 845 | $8K | |
| 85007 | <1% | 1,681 | $8K | |
| 81015 | <1% | 2,091 | $7K | |
| 87040 | <1% | 267 | $7K | |
| 82570 | <1% | 1,072 | $7K | |
| 90715 | <1% | 230 | $6K | |
| 82803 | <1% | 106 | $6K | |
| 96376 | <1% | 113 | $5K | |
| 85651 | <1% | 1,016 | $5K | |
| 87507 | <1% | 13 | $4K | |
| 86703 | <1% | 150 | $4K | |
| 94760 | <1% | 241 | $4K | |
| 82150 | <1% | 312 | $4K | |
| 87205 | <1% | 472 | $3K | |
| 73080 | <1% | 54 | $3K | |
| 84550 | <1% | 447 | $3K | |
| 82553 | <1% | 158 | $3K | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 329 | $3K |
| 84403 | <1% | 73 | $3K | |
| 86038 | <1% | 174 | $2K | |
| 12011 | <1% | 12 | $2K | |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 210 | $2K |
| 82962 | <1% | 308 | $2K | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 357 | $2K |
| 82248 | <1% | 180 | $2K | |
| 73502 | <1% | 16 | $2K | |
| 72110 | <1% | 14 | $2K | |
| 73090 | <1% | 27 | $2K | |
| 82077 | <1% | 65 | $2K | |
| 74022 | <1% | 20 | $1K | |
| 80320 | <1% | 58 | $1K | |
| 82746 | <1% | 91 | $1K | |
| 97161 | <1% | 12 | $1K | |
| 36416 | <1% | 119 | $1K | |
| 82652 | <1% | 19 | $923.43 | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 31 | $881.67 |
| 80076 | <1% | 85 | $863.70 | |
| 76010 | <1% | 13 | $567.87 | |
| 86901 | <1% | 88 | $458.17 | |
| 86431 | <1% | 70 | $452.12 | |
| 81003 | <1% | 108 | $434.92 | |
| 86769 | <1% | 14 | $418.29 | |
| 87220 | <1% | 49 | $324.76 | |
| 82784 | <1% | 14 | $312.16 | |
| 86900 | <1% | 88 | $308.72 | |
| 87210 | <1% | 55 | $269.94 | |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 16 | $195.72 |
| 86850 | <1% | 16 | $114.33 | |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | <1% | 18 | $32.36 |
| A9270 | Non-covered item or service | 0% | 14 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialJACKSON, MICHAEL (PRESIDENT)
| Provider | Location | Paid |
|---|---|---|
| Home Helpers | Boise, ID | $2K |
| Doctor's Professional Services Consultants, INC | Stuart, FL | $59.89 |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.